Tracking the KZIA expected move helps you see how far Kazia Therapeutics Limited ADR's options market is pricing the stock to travel over a given period — whether that's the next day, week, or earnings cycle. Kazia Therapeutics Limited ADR's expected move is derived directly from option premiums and gives you an objective range to plan trades, set strikes, and manage risk. Use our scanner to monitor the KZIA expected move for this week's options, in real time.
The expected move is typically calculated from at-the-money straddle prices (or a blend of straddles and strangles) and represents roughly a one-standard-deviation range over the chosen timeframe. For KZIA, comparing the implied expected move to actual realized moves over similar windows tells you whether the options market has historically overestimated or underestimated volatility. The KZIA expected move for this week's options pricing is especially useful for short-dated traders, earnings players, and anyone selling premium who needs to know where the market thinks Kazia Therapeutics Limited ADR is unlikely to go.
Kazia Therapeutics Limited, an oncology-focused biotechnology company, develops anti-cancer drugs. Its lead development candidate is Paxalisib, a small molecule, brain-penetrant inhibitor of the PI3K/Akt/mTor pathway, which is developed as a potential therapy for glioblastoma. It is also developing EVT801, an investigational new drug for various forms of cancer. The company was formerly known as Novogen Limited and changed its name to Kazia Therapeutics Limited in November 2017. Kazia Therapeutics Limited was incorporated in 1994 and is based in Sydney, Australia.
Iron condors, weekly premium sales, directional swing trades — they all live or die by where the market thinks the stock won't go. Our scanner tracks the KZIA expected move across every expiration, benchmarks it against realized moves, and shows you when implied ranges are out of line with history. The Kazia Therapeutics Limited ADR expected move for this week's options is the fastest read on short-term risk, which gives you a quick way to interpret what the options market thinks about KZIA.
